Stonvex publishes market data and research only. Not investment advice. Not a registered investment advisor. Read disclaimer.

RCEL

Live52w high -38.4%

Core line items from RCEL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.

Financial statements

Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.

Entity: AVITA MEDICAL, INC.·Source: SEC EDGAR companyfacts

Metric	Annual 2025 2025-12-31	Annual 2024 2024-12-31	Annual 2023 2023-12-31
Revenue	$70.88M	$63.89M	$50.14M
Operating Income	$-42.53M	$-56.59M	$-42.66M
Net Income	$-48.59M	$-61.84M	$-35.38M
EPS (Diluted)	$-1.74	$-2.39	$-1.40
Total Assets	$56.39M	$79.71M	$111.64M
Total Liabilities	$73.04M	$74.97M	$61.89M
Cash & Equivalents	$10.24M	$14.05M	$22.12M
Free Cash Flow OCF − CapEx	$-32.20M	$-58.11M	$-39.39M
Shares Outstanding	30.57M	26.35M	25.68M

Financial data is sourced from public SEC filings where available. Some metrics may be unavailable without premium market data.

Core line items from RCEL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.

52w high -38.4%

Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.

Entity: AVITA MEDICAL, INC.·Source: SEC EDGAR companyfacts

Metric	Annual 2025 2025-12-31	Annual 2024 2024-12-31	Annual 2023 2023-12-31
Revenue	$70.88M	$63.89M	$50.14M
Operating Income	$-42.53M	$-56.59M	$-42.66M
Net Income	$-48.59M	$-61.84M	$-35.38M
EPS (Diluted)	$-1.74	$-2.39	$-1.40
Total Assets	$56.39M	$79.71M	$111.64M
Total Liabilities	$73.04M	$74.97M	$61.89M
Cash & Equivalents	$10.24M	$14.05M	$22.12M
Free Cash Flow OCF − CapEx	$-32.20M	$-58.11M	$-39.39M
Shares Outstanding	30.57M	26.35M	25.68M

Financial data is sourced from public SEC filings where available. Some metrics may be unavailable without premium market data.